Mitesh Borad, MD


Dr. Borad, MD, is a graduate of New Jersey Medical School in Newark, New Jersey. He did his residency in Internal Medicine at the Cedars-Sinai Medical Center and Medical Oncology Fellowship at Tulane University School of Medicine. Thereafter, he was a Genomics Medicine/ Drug Development Scholar at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona. Dr. Borad is currently Associate Director of Phase I Drug Development at the Mayo Clinic in Arizona. He is actively involved in all aspects of Phase I and Phase II clinical trials for investigational oncology drugs. Dr. Borad's research interests include: Phase I drug development, Pancreatic cancer, Biliary cancer (Cholangiocarcinoma), Liver cancer (Hepatocellular carcinoma), Genomic/novel clinical trial designs, whole genome next generation sequencing and Rare cancers: Adrenocortical cancer, Metastatic basal cell cancer, Pheochromocytoma, Gastrointestinal stromal tumor (GIST).